Serina Therapeutics, Inc. Operating Expenses
Serina Therapeutics, Inc. (SER) reported Operating Expenses of $6.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- Serina Therapeutics, Inc. operating expenses for the quarter ending 2026-06-30 was $6.78M, a 19.12% increase year-over-year.
- Serina Therapeutics, Inc. operating expenses for the quarter ending 2026-03-31 was $6.28M, a 7.20% increase year-over-year.
- Serina Therapeutics, Inc. operating expenses for the quarter ending 2025-12-31 was $6.21M, a 12.14% increase year-over-year.
- Serina Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $6.39M, a 20.02% increase year-over-year.
- Serina Therapeutics, Inc. operating expenses for fiscal 2025 was $24.15M, a 41.21% increase from fiscal 2024.
- Serina Therapeutics, Inc. operating expenses for fiscal 2024 was $17.10M, a 172.27% increase from fiscal 2023.
- Serina Therapeutics, Inc. operating expenses for fiscal 2023 was $6.28M, a 10.21% decline from fiscal 2022.
- Serina Therapeutics, Inc. operating expenses for fiscal 2022 was $7.00M, a 14.31% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.78M 10-Q · filed 2026-08-13 | $13.06M 10-Q · filed 2026-08-13 | $19.27M derived: sum of 3 quarters · filed 2026-08-13 | $25.66M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $6.28M 10-Q · filed 2026-05-14 | $12.49M derived: sum of 2 quarters · filed 2026-05-14 | $18.88M derived: sum of 3 quarters · filed 2026-05-14 | $24.57M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $12.60M derived: sum of 2 quarters · filed 2026-03-25 | $18.29M derived: sum of 3 quarters · filed 2026-08-13 | $24.15M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $6.39M 10-Q · filed 2025-11-13 | $12.09M derived: sum of 2 quarters · filed 2026-08-13 | $17.95M 10-Q · filed 2025-11-13 | $23.48M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $5.70M 10-Q · filed 2026-08-13 | $11.55M 10-Q · filed 2026-08-13 | $17.09M derived: sum of 3 quarters · filed 2026-08-13 | $22.41M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $5.86M 10-Q · filed 2026-05-14 | $11.39M derived: sum of 2 quarters · filed 2026-05-14 | $16.72M derived: sum of 3 quarters · filed 2026-05-14 | $20.64M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $10.86M derived: sum of 2 quarters · filed 2026-03-25 | $14.78M derived: sum of 3 quarters · filed 2026-03-25 | $17.10M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $5.33M 10-Q · filed 2025-11-13 | $9.24M derived: sum of 2 quarters · filed 2025-11-13 | $11.57M 10-Q · filed 2025-11-13 | $14.41M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $3.92M 10-Q · filed 2025-08-11 | $6.24M 10-Q · filed 2025-08-11 | $9.09M derived: sum of 3 quarters · filed 2025-08-11 | $10.58M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $2.33M 10-Q · filed 2025-05-08 | $5.17M derived: sum of 2 quarters · filed 2025-05-08 | $6.66M derived: sum of 3 quarters · filed 2025-05-08 | $7.62M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $4.34M derived: sum of 2 quarters · filed 2025-03-24 | $5.29M derived: sum of 3 quarters · filed 2025-03-24 | $6.28M 10-K · filed 2025-03-24 | $10.06M 10-K · filed 2024-03-22 | |||
| 2023-09-30 | $1.49M 10-Q · filed 2024-11-12 | $2.39M 10-Q · filed 2023-11-14 | $2.44M derived: sum of 2 quarters · filed 2024-11-12 | $3.44M 10-Q · filed 2024-11-12 | $6.45M 10-Q · filed 2023-11-14 | $5.22M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $952.00K 10-Q · filed 2024-08-09 | $1.89M 10-Q · filed 2023-08-14 | $1.94M 10-Q · filed 2024-08-09 | $4.06M 10-Q · filed 2023-08-14 | $3.73M derived: sum of 3 quarters · filed 2024-08-09 | $5.29M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $992.00K 10-Q · filed 2024-05-14 | $2.17M 10-Q · filed 2023-05-12 | $2.78M derived: sum of 2 quarters · filed 2024-05-14 | $4.33M derived: sum of 3 quarters · filed 2024-05-14 | $5.93M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $3.34M derived: sum of 2 quarters · filed 2024-03-22 | $4.94M derived: sum of 3 quarters · filed 2024-03-22 | $7.00M 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | $1.55M 10-Q · filed 2023-11-14 | $3.15M derived: sum of 2 quarters · filed 2023-11-14 | $5.21M 10-Q · filed 2023-11-14 | $7.10M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $1.60M 10-Q · filed 2023-08-14 | $3.65M 10-Q · filed 2023-08-14 | $5.55M derived: sum of 3 quarters · filed 2023-08-14 | $7.24M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $2.06M 10-Q · filed 2023-05-12 | $3.95M derived: sum of 2 quarters · filed 2023-05-12 | $5.64M derived: sum of 3 quarters · filed 2023-05-12 | $7.87M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.59M derived: sum of 2 quarters · filed 2023-03-31 | $5.82M derived: sum of 3 quarters · filed 2023-03-31 | $8.16M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $1.70M 10-Q · filed 2022-11-10 | $3.92M derived: sum of 2 quarters · filed 2022-11-10 | $6.27M 10-Q · filed 2022-11-10 | $8.75M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $2.23M 10-Q · filed 2022-08-12 | $4.58M 10-Q · filed 2022-08-12 | $7.05M derived: sum of 3 quarters · filed 2022-08-12 | $9.50M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $2.35M 10-Q · filed 2022-05-13 | $4.83M derived: sum of 2 quarters · filed 2022-05-13 | $7.28M derived: sum of 3 quarters · filed 2022-05-13 | $9.69M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $4.93M derived: sum of 2 quarters · filed 2022-03-29 | $7.34M derived: sum of 3 quarters · filed 2022-03-29 | $10.44M 10-K · filed 2022-03-29 | $12.38M 10-K · filed 2021-03-31 | |||
| 2020-09-30 | $2.45M 10-Q · filed 2021-11-12 | $2.79M 10-Q · filed 2020-11-16 | $4.86M derived: sum of 2 quarters · filed 2021-11-12 | $7.96M 10-Q · filed 2021-11-12 | $9.47M 10-Q · filed 2020-11-16 | $11.14M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $2.41M 10-Q · filed 2021-08-13 | $3.00M 10-Q · filed 2020-08-14 | $5.51M 10-Q · filed 2021-08-13 | $6.68M 10-Q · filed 2020-08-14 | $8.69M derived: sum of 3 quarters · filed 2021-08-13 | $12.33M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $3.10M 10-Q · filed 2021-05-17 | -$3.68M 10-Q · filed 2020-05-14 | $6.28M derived: sum of 2 quarters · filed 2021-05-17 | $9.92M derived: sum of 3 quarters · filed 2021-05-17 | $13.69M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $6.83M derived: sum of 2 quarters · filed 2021-03-31 | $10.60M derived: sum of 3 quarters · filed 2021-03-31 | $14.04M 10-K · filed 2021-03-31 | -$14.04M 10-K/A · filed 2020-03-31 | |||
| 2019-09-30 | $3.64M 10-Q · filed 2020-11-16 | -$3.64M 10-Q · filed 2019-11-14 | $7.41M derived: sum of 2 quarters · filed 2020-11-16 | $10.86M 10-Q · filed 2020-11-16 | -$10.86M 10-Q · filed 2019-11-14 | $472.00K derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $3.77M 10-Q · filed 2020-08-14 | $7.22M 10-Q · filed 2020-08-14 | -$3.17M derived: sum of 3 quarters · filed 2020-08-14 | -$5.75M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$3.45M 10-Q · filed 2020-05-14 | $3.45M 10-Q · filed 2019-05-15 | -$6.94M derived: sum of 2 quarters · filed 2020-05-14 | -$9.52M derived: sum of 3 quarters · filed 2020-05-14 | -$7.00M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | -$3.49M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | -$6.08M derived: sum of 2 quarters · filed 2020-03-31 | -$3.56M derived: sum of 3 quarters · filed 2020-03-31 | -$12.28M 10-K/A · filed 2020-03-31 | $12.28M 10-K · filed 2019-04-01 | |||
| 2018-09-30 | -$2.59M 10-Q · filed 2019-11-14 | -$67.00K derived: sum of 2 quarters · filed 2019-11-14 | -$8.79M 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $2.52M 10-Q · filed 2019-08-14 | $6.20M 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | $3.68M 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | $9.65M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |